Cargando…
Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma
INTRODUCTION: Hepatocellular carcinoma (HCC) accounts for 80% of all liver cancers and is the 2nd leading cause of cancer-related death in Taiwan. Various factors, including rapid cell growth, a high recurrence rate and drug resistance, make HCC difficult to cure. Moreover, the survival rate of adva...
Autores principales: | Li, Chao-Jen, Tsai, Hung-Wen, Chen, Yi-Li, Wang, Chun-I, Lin, Yang-Hsiang, Chu, Pei-Ming, Chi, Hsiang-Cheng, Huang, Yi-Ching, Chen, Cheng-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896975/ https://www.ncbi.nlm.nih.gov/pubmed/36741246 http://dx.doi.org/10.2147/JHC.S385238 |
Ejemplares similares
-
8-Hydroxydaidzein Downregulates JAK/STAT, MMP, Oxidative Phosphorylation, and PI3K/AKT Pathways in K562 Cells
por: Wu, Pei-Shan, et al.
Publicado: (2021) -
CEP55 Promotes Cell Motility via JAK2–STAT3–MMPs Cascade in Hepatocellular Carcinoma
por: Li, Minjing, et al.
Publicado: (2018) -
Hypoxia-Induced Activation of JAK/STAT3 Signaling Pathway Promotes Trophoblast Cell Viability and Angiogenesis in Preeclampsia
por: Xu, Chengfang, et al.
Publicado: (2017) -
Piperlongumine Induces Apoptosis and Synergizes with Doxorubicin by Inhibiting the JAK2-STAT3 Pathway in Triple-Negative Breast Cancer
por: Chen, Di, et al.
Publicado: (2019) -
JAK/STAT and Hox Dynamic Interactions in an Organogenetic Gene Cascade
por: Pinto, Pedro B., et al.
Publicado: (2015)